Search

everythinglearnresearchcommunity

for

Search:↓

Hypochlorous acid spray improves wound healing and reduces redness and itching in hair transplant surgery.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

A new compound was made to detect copper ions effectively.

Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

A new one-step test can quickly identify skin cancer during surgery.

Online skin care companies offer easy access to treatments but may have ethical issues like confirming patient identity, prescribing unproven therapies, and not fully explaining medication side effects. They should prioritize patient care over profit.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

A homeopathic antidandruff shampoo caused severe hair matting in a girl.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

The new fluoroquinolone effectively fights certain bacteria.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

The bio-based complex effectively repairs and protects chemically damaged hair.

Liposomes with butterfly pea extract and clove oil are stable and effective according to users.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.